Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
18 05 2020
Historique:
pubmed: 13 5 2020
medline: 10 3 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

Background The balance between ischemic and bleeding events and their association with platelet reactivity in patients receiving antiplatelet therapy after percutaneous coronary intervention (PCI), which differs among regions, is not fully evaluated for East Asians. We examined ischemic/bleeding events and platelet reactivity in Japanese patients undergoing PCI and determined associations between high/low platelet reactivity and clinical outcomes. Methods and Results PENDULUM (Platelet Reactivity in Patients with Drug Eluting Stent and Balancing Risk of Bleeding and Ischemic Event) is a prospective, multicenter registry of Japanese patients with PCI. Primary end points were incidence of first major adverse cardiac and cerebrovascular events (MACCE) and first major bleeding events at 12 months post-PCI. Platelet reactivity (P2Y

Identifiants

pubmed: 32394794
doi: 10.1161/JAHA.119.015439
pmc: PMC7660889
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0
Purinergic P2Y Receptor Antagonists 0

Banques de données

UMIN-CTR
['UMIN 000020332']

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015439

Commentaires et corrections

Type : ErratumIn

Références

J Am Coll Cardiol. 2013 Feb 5;61(5):536-44
pubmed: 23273394
Thromb Haemost. 2019 Jan;119(1):149-162
pubmed: 30597509
Am Heart J. 2015 Dec;170(6):1077-85
pubmed: 26678628
Circ Cardiovasc Interv. 2018 Nov;11(11):e006243
pubmed: 30571206
Circulation. 2019 Dec 3;140(23):1865-1877
pubmed: 31553203
JAMA Cardiol. 2017 May 1;2(5):478-487
pubmed: 28297015
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537
pubmed: 31202949
Circulation. 2012 Sep 4;126(10):1225-36
pubmed: 22824435
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
JAMA. 2011 Mar 16;305(11):1097-105
pubmed: 21406646
JAMA. 2019 Jun 25;321(24):2414-2427
pubmed: 31237644
Am J Cardiol. 2005 Nov 1;96(9):1200-6
pubmed: 16253582
Lancet. 2013 Aug 17;382(9892):614-23
pubmed: 23890998
J Neurol Sci. 2009 Dec 15;287(1-2):45-51
pubmed: 19815240
Lancet. 2018 Jan 6;391(10115):41-50
pubmed: 29102362
J Am Heart Assoc. 2020 May 18;9(10):e015439
pubmed: 32394794
Am Heart J. 2011 Jan;161(1):5-12.e5
pubmed: 21167334
Circ J. 2013;77(6):1590-607
pubmed: 23657129
Circ J. 2019 Feb 25;83(3):637-646
pubmed: 30674776
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
Circ Cardiovasc Interv. 2012 Jun;5(3):381-91
pubmed: 22619260
Circ J. 2014;78(12):2926-34
pubmed: 25342212
Lancet. 2017 Mar 11;389(10073):1025-1034
pubmed: 28290994
Int J Cardiol. 2015 Mar 1;182:541-8
pubmed: 25679803
Cardiovasc Interv Ther. 2019 Oct;34(4):297-304
pubmed: 30847655
J Am Coll Cardiol. 2016 May 17;67(19):2224-2234
pubmed: 27079334
Lancet. 2013 Nov 23;382(9906):1714-22
pubmed: 24004642
N Engl J Med. 2007 Nov 15;357(20):2001-15
pubmed: 17982182
Eur Heart J. 2019 Aug 14;40(31):2632-2653
pubmed: 31116395
Eur Heart J. 2019 Jun 21;40(24):1942-1951
pubmed: 31226213
Am Heart J. 2009 Apr;157(4):658-65
pubmed: 19332192
J Am Coll Cardiol. 2013 Jul 16;62(3):181-190
pubmed: 23684673
Cardiovasc Interv Ther. 2015 Apr;30(2):103-14
pubmed: 24969222
Circ J. 2014;78(7):1684-92
pubmed: 24759796
J Am Coll Cardiol. 2019 Feb 26;73(7):741-754
pubmed: 30784667
Nihon Rinsho. 2011 Nov;69 Suppl 9:573-82
pubmed: 22724265
JAMA. 2007 Mar 21;297(11):1197-206
pubmed: 17374814
Circ J. 2015;79(11):2452-60
pubmed: 26376600

Auteurs

Masato Nakamura (M)

Division of Cardiovascular Medicine Toho University Ohashi Medical Center Tokyo Japan.

Kazushige Kadota (K)

Department of Cardiology Kurashiki Central Hospital Kurashiki Japan.

Akihiko Takahashi (A)

Department of Cardiology Sakurakai Takahashi Hospital Kobe Japan.

Junji Kanda (J)

Department of Cardiology Asahi General Hospital Asahi Japan.

Hitoshi Anzai (H)

Department of Cardiology Ota Memorial Hospital Ota Japan.

Yasuhiro Ishii (Y)

Department of Cardiology Cardiovascular Center Ogikubo Hospital Tokyo Japan.

Yoshisato Shibata (Y)

Department of Cardiology Miyazaki Medical Association Hospital Miyazaki Japan.

Yoshinori Yasaka (Y)

Department of Cardiology Himeji Cardiovascular Center Himeji Japan.

Itaru Takamisawa (I)

Department of Cardiology Sakakibara Heart Institute Tokyo Japan.

Junichi Yamaguchi (J)

Department of Cardiology Tokyo Women's Medical University Tokyo Japan.

Yoshihiro Takeda (Y)

Department of Cardiology Rinku General Medical Center Izumisano Japan.

Atsushi Harada (A)

Medical Science Department Daiichi Sankyo Co., Ltd. Tokyo Japan.

Tomoko Motohashi (T)

Medical Affairs Planning Department Daiichi Sankyo Co., Ltd. Tokyo Japan.

Raisuke Iijima (R)

Division of Cardiovascular Medicine Toho University Ohashi Medical Center Tokyo Japan.

Shiro Uemura (S)

Department of Cardiology Kawasaki Medical School Kurashiki Japan.

Yoshitaka Murakami (Y)

Department of Medical Statistics School of Medicine Toho University Tokyo Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH